Stay updated on Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.

Latest updates to the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page
- Check2 days agoChange DetectedA new page revision label (v3.3.3) was added, and the HHS Vulnerability Disclosure link along with the previous revision label (v3.3.2) were removed from the footer.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 was added to the history list, replacing Revision: v3.2.0. This is a minor UI-label update on the study history page and does not affect core study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the government funding/operating status notice from the page, eliminating guidance that information may not be up to date and that submissions might not be processed during funding lapses.SummaryDifference0.5%

- Check52 days agoChange DetectedThe old and new screenshots show the same record history content with no new version data or status changes; differences are limited to layout and styling. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedMajor change: version upgraded to v3.2.0 and new government-operating-status notice added; old version reference v3.1.0 removed.SummaryDifference11%

- Check88 days agoChange DetectedIncremental version update from v3.0.2 to v3.1.0 with no substantive content changes. If there were conflicting signals, the version bump takes precedence as the primary change.SummaryDifference0.3%

Stay in the know with updates to Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.